Effectiveness of Vitamin D Supplements among Patients Hospitalized for COVID-19: Results from a Monocentric Matched-Cohort Study
Vito Fiore, Andrea De Vito, Paola Bagella, Elija Princic, Anna Antonella Mariani, Lucia Denti, Alessandro Giuseppe Fois, Giordano Madeddu, Sergio Babudieri, Ivana Maida
Healthcare, doi:10.3390/healthcare10050956
Objectives: Our study aimed to evaluate the usefulness of Vitamin D3 (VitD3) among patients hospitalized for COVID-19. The primary endpoint was to evaluate the difference in survival rates between patients receiving and not VitD3. The secondary endpoints were to evaluate clinical outcomes, such as needing non-invasive ventilation (NIV), ICU transfer, and laboratory findings (inflammatory parameters). Methods: We conducted a retrospective, monocentric matched-cohort study, including patients attending our ward for COVID-19. Patients were divided into two groups depending on VitD3 administration (Group A) or not (Group B) among patients with low VitD levels (defined as blood levels < 30 ng/mL), which depended on physicians' judgment. Our internal protocol provides VitD3 100,000 UI/daily for two days. Findings: 58 patients were included in Group A, and 58 in Group B. Patients were matched for age, sex, comorbidities, COVID-19-related symptoms, PaO2/FiO2 ratio, blood exams, and medical treatments. Regarding the principal endpoint, there was a statistically significant difference between the two groups in survival rates [Group A vs. Group B = 3 vs. 11 (p = 0.042)]. When considering secondary endpoints, Group A patients were less likely to undergo NIV [Group A vs. Group B = 12 vs. 23 (p = 0.026)] and showed an improvement in almost all inflammatory parameters. Conclusions: The link between VitD3 deficiency and the clinical course of COVID-19 during hospitalization suggests that VitD3 level is a useful prognostic marker. Considering the safety of supplementation and the low cost, VitD3 replacement should be considered among SARS-CoV-2 infected patients needing hospitalization.
Author Contributions: V.F. and I.M. conceived the study. V.F., I.M., A.D.V., A.G.F., G.M., S.B., P.B., E.P., A.A.M. and L.D. organized the database. V.F. and A.D.V. performed statistical analysis. A.G.F., G.M., S.B. and I.M. supervised the study. V.F., A.D.V., P.B. and E.P. produced the manuscripts' first draft. All authors contributed to manuscript revision. All authors have read and agreed to the published version of the manuscript.
Conflicts of Interest: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
References
Annweiler, Corvaisier, Gautier, Dubée, Legrand et al., Vitamin D supplementation associated to better survival in hospitalized frail elderly COVID-19 patients: The GERIA-COVID quasi-experimental study, Nutrients,
doi:10.3390/nu12113377Annweiler, Hanotte, Grandin De L'eprevier, Sabatier, Lafaie et al., Vitamin D and survival in COVID-19 patients: A quasi-experimental study, J. Steroid Biochem. Mol. Biol,
doi:10.1016/j.jsbmb.2020.105771Barlow, Svoboda, Mackellar, Nash, York et al., Antiviral activity and increased host defense against influenza infection elicited by the human cathelicidin LL-37, PLoS ONE,
doi:10.1371/journal.pone.0025333Bouillon, Marcocci, Carmeliet, White, Dawson-Hughes et al., Skeletal and extraskeletal actions of Vitamin D: Current evidence and outstanding questions, Endocr. Rev,
doi:10.1210/er.2018-00126Castillo, Entrenas Costa, Vaquero Barrios, Alcalá Díaz, López Miranda et al., Effect of calcifediol treatment and best available therapy versus best available therapy on intensive care unit admission and mortality among patients hospitalized for COVID-19: A pilot randomized clinical study, J. Steroid Biochem. Mol. Biol,
doi:10.1016/j.jsbmb.2020.105751Chiodini, Gatti, Soranna, Merlotti, Mingiano et al., Vitamin D Status and SARS-CoV-2 Infection and COVID-19 Clinical Outcomes, Front. Public Health,
doi:10.3389/fpubh.2021.736665Covino, De Matteis, Santoro, Sabia, Simeoni et al., Clinical characteristics and prognostic factors in COVID-19 patients aged ≥80 years, Geriatr. Gerontol. Int,
doi:10.1111/ggi.13960De, Vito, Fiore, Princic, Geremia et al., Predictors of infection, symptoms development, and mortality in people with SARS-CoV-2 living in retirement nursing homes, PLoS ONE,
doi:10.1371/journal.pone.0248009De, Vito, Geremia, Fiore, Princic et al., Clinical features, laboratory findings and predictors of death in hospitalized patients with COVID-19 in Sardinia, Italy, Eur. Rev. Med. Pharmacol. Sci
De, Vito, Geremia, Princic, Fanelli et al., Does Angiotensin II receptor blockers increase the risk of SARS-CoV-2 infection? A real-life experience, Eur. Rev. Med. Pharmacol. Sci
Dror, Morozov, Daoud, Namir, Yakir et al., Pre-infection 25-hydroxyvitamin D3 levels and association with severity of COVID-19 illness, PLoS ONE,
doi:10.1371/journal.pone.0263069Du, Liang, Yang, Wang, Cao et al., Predictors of mortality for patients with COVID-19 pneumonia caused by SARSCoV-2: A prospective cohort study, Eur. Respir. J,
doi:10.1183/13993003.00524-2020Fiore, Beretta, De Vito, Barac, Maida et al., Emerging Clinical Features of COVID-19 Related Pancreatitis: Case Reports and Review of the Literature, Front. Med,
doi:10.3389/fmed.2021.779118Fiore, De Vito, Fanelli, Geremia, Princic et al., Mood Reactive Disorders among COVID-19 Inpatients: Experience from a Monocentric Cohort, Med. Princ. Pract,
doi:10.1159/000518490Imai, Kuba, Rao, Huan, Guo et al., Angiotensin-converting enzyme 2 protects from severe acute lung failure, Nature,
doi:10.1038/nature03712Jaun, Boesing, Lüthi-Corridori, Abig, Makhdoomi et al., High-dose vitamin D substitution in patients with COVID-19: Study protocol for a randomized, double-blind, placebo-controlled, multi-center study-VitCov Trial, Trials,
doi:10.1186/s13063-022-06016-2Kim, Yang, Jang, Jang, Human beta-defensin 2 plays a regulatory role in innate antiviral immunity and is capable of potentiating the induction of antigen-specific immunity, Virol. J,
doi:10.1186/s12985-018-1035-2Liu, Chen, Lin, Han, Clinical features of COVID-19 in elderly patients: A comparison with young and middle-aged patients, J. Infect,
doi:10.1016/j.jinf.2020.03.005Liu, Stenger, Li, Wenzel, Tan et al., Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response, Science,
doi:10.1126/science.1123933Martha, Wibowo, Pranata, Prognostic value of elevated lactate dehydrogenase in patients with COVID-19: A systematic review and meta-analysis, Postgrad. Med. J,
doi:10.1136/postgradmedj-2020-139542Martineau, Jolliffe, Hooper, Greenberg, Aloia et al., Vitamin D supplementation to prevent acute respiratory tract infections: Systematic review and meta-analysis of individual participant data, BMJ,
doi:10.1136/bmj.i6583Murai, Fernandes, Sales, Pinto, Goessler et al., Effect of a single high dose of Vitamin D3 on hospital length of stay in patients with moderate to severe COVID-19: A randomized clinical trial, JAMA,
doi:10.1001/jama.2020.26848Niu, Tian, Lou, Kang, Zhang et al., Clinical characteristics of older patients infected with COVID-19: A descriptive study, Arch. Gerontol. Geriatr,
doi:10.1016/j.archger.2020.104058Quesada-Gomez, Entrenas-Castillo, Bouillon, Vitamin D receptor stimulation to reduce acute respiratory distress syndrome (ARDS) in patients with coronavirus SARS-CoV-2 infections, J. Steroid Biochem. Mol. Biol,
doi:10.1016/j.jsbmb.2020.105719Rodriguez-Guerra, Jadhav, Vittorio, Current treatment in COVID-19 disease: A rapid review, Drugs Context,
doi:10.7573/dic.2020-10-3Saravolatz, Depcinski, Sharma, Molnupiravir and Nirmatrelvir-Ritonavir: Oral COVID Antiviral Drugs, Clin. Infect. Dis,
doi:10.1093/cid/ciac180Vaira, Hopkins, Salzano, Petrocelli, Melis et al., Olfactory and gustatory function impairment in COVID-19 patients: Italian objective multicenter-study, Head Neck,
doi:10.1002/hed.26269Wang, Nestel, Bourdeau, Nagai, Wang et al., Cutting edge: 1,25-dihydroxyvitamin D3 is a direct inducer of antimicrobial peptide gene expression, J. Immunol,
doi:10.4049/jimmunol.173.5.2909Xu, Yang, Chen, Luo, Zhang et al., Vitamin D alleviates lipopolysaccharide-induced acute lung injury via regulation of the renin-angiotensin system, Mol. Med. Rep,
doi:10.3892/mmr.2017.7546Yang, Petitjean, Koehler, Zhang, Dumitru et al., Molecular interaction and inhibition of SARS-CoV-2 binding to the ACE2 receptor, Nat. Commun,
doi:10.1038/s41467-021-23498-xZhou, Yu, Du, Fan, Liu et al., Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: A retrospective cohort study, Lancet,
doi:10.1016/S0140-6736(20)30566-3Zinellu, De Vito, Scano, Paliogiannis, Fiore et al., The PaO2/FiO2 ratio on admission is independently associated with prolonged hospitalization in COVID-19 patients, J. Infect. Dev. Ctries,
doi:10.3855/jidc.13288DOI record:
{
"DOI": "10.3390/healthcare10050956",
"ISSN": [
"2227-9032"
],
"URL": "http://dx.doi.org/10.3390/healthcare10050956",
"abstract": "<jats:p>Objectives: Our study aimed to evaluate the usefulness of Vitamin D3 (VitD3) among patients hospitalized for COVID-19. The primary endpoint was to evaluate the difference in survival rates between patients receiving and not VitD3. The secondary endpoints were to evaluate clinical outcomes, such as needing non-invasive ventilation (NIV), ICU transfer, and laboratory findings (inflammatory parameters). Methods: We conducted a retrospective, monocentric matched-cohort study, including patients attending our ward for COVID-19. Patients were divided into two groups depending on VitD3 administration (Group A) or not (Group B) among patients with low VitD levels (defined as blood levels < 30 ng/mL), which depended on physicians’ judgment. Our internal protocol provides VitD3 100,000 UI/daily for two days. Findings: 58 patients were included in Group A, and 58 in Group B. Patients were matched for age, sex, comorbidities, COVID-19-related symptoms, PaO2/FiO2 ratio, blood exams, and medical treatments. Regarding the principal endpoint, there was a statistically significant difference between the two groups in survival rates [Group A vs. Group B = 3 vs. 11 (p = 0.042)]. When considering secondary endpoints, Group A patients were less likely to undergo NIV [Group A vs. Group B = 12 vs. 23 (p = 0.026)] and showed an improvement in almost all inflammatory parameters. Conclusions: The link between VitD3 deficiency and the clinical course of COVID-19 during hospitalization suggests that VitD3 level is a useful prognostic marker. Considering the safety of supplementation and the low cost, VitD3 replacement should be considered among SARS-CoV-2 infected patients needing hospitalization.</jats:p>",
"alternative-id": [
"healthcare10050956"
],
"author": [
{
"ORCID": "http://orcid.org/0000-0002-7444-1920",
"affiliation": [],
"authenticated-orcid": false,
"family": "Fiore",
"given": "Vito",
"sequence": "first"
},
{
"ORCID": "http://orcid.org/0000-0002-8265-5400",
"affiliation": [],
"authenticated-orcid": false,
"family": "De Vito",
"given": "Andrea",
"sequence": "additional"
},
{
"affiliation": [],
"family": "Bagella",
"given": "Paola",
"sequence": "additional"
},
{
"affiliation": [],
"family": "Princic",
"given": "Elija",
"sequence": "additional"
},
{
"ORCID": "http://orcid.org/0000-0003-1697-3694",
"affiliation": [],
"authenticated-orcid": false,
"family": "Mariani",
"given": "Anna Antonella",
"sequence": "additional"
},
{
"affiliation": [],
"family": "Denti",
"given": "Lucia",
"sequence": "additional"
},
{
"ORCID": "http://orcid.org/0000-0001-5330-572X",
"affiliation": [],
"authenticated-orcid": false,
"family": "Fois",
"given": "Alessandro Giuseppe",
"sequence": "additional"
},
{
"ORCID": "http://orcid.org/0000-0001-6099-2273",
"affiliation": [],
"authenticated-orcid": false,
"family": "Madeddu",
"given": "Giordano",
"sequence": "additional"
},
{
"ORCID": "http://orcid.org/0000-0001-7291-8687",
"affiliation": [],
"authenticated-orcid": false,
"family": "Babudieri",
"given": "Sergio",
"sequence": "additional"
},
{
"affiliation": [],
"family": "Maida",
"given": "Ivana",
"sequence": "additional"
}
],
"container-title": "Healthcare",
"container-title-short": "Healthcare",
"content-domain": {
"crossmark-restriction": false,
"domain": []
},
"created": {
"date-parts": [
[
2022,
5,
22
]
],
"date-time": "2022-05-22T11:13:57Z",
"timestamp": 1653218037000
},
"deposited": {
"date-parts": [
[
2022,
5,
22
]
],
"date-time": "2022-05-22T11:23:43Z",
"timestamp": 1653218623000
},
"indexed": {
"date-parts": [
[
2022,
5,
22
]
],
"date-time": "2022-05-22T11:41:28Z",
"timestamp": 1653219688059
},
"is-referenced-by-count": 0,
"issue": "5",
"issued": {
"date-parts": [
[
2022,
5,
22
]
]
},
"journal-issue": {
"issue": "5",
"published-online": {
"date-parts": [
[
2022,
5
]
]
}
},
"language": "en",
"license": [
{
"URL": "https://creativecommons.org/licenses/by/4.0/",
"content-version": "vor",
"delay-in-days": 0,
"start": {
"date-parts": [
[
2022,
5,
22
]
],
"date-time": "2022-05-22T00:00:00Z",
"timestamp": 1653177600000
}
}
],
"link": [
{
"URL": "https://www.mdpi.com/2227-9032/10/5/956/pdf",
"content-type": "unspecified",
"content-version": "vor",
"intended-application": "similarity-checking"
}
],
"member": "1968",
"original-title": [],
"page": "956",
"prefix": "10.3390",
"published": {
"date-parts": [
[
2022,
5,
22
]
]
},
"published-online": {
"date-parts": [
[
2022,
5,
22
]
]
},
"publisher": "MDPI AG",
"reference": [
{
"key": "ref1"
},
{
"key": "ref2",
"unstructured": "New-Type Coronavirus Causes Pneumonia in Wuhan: Expert—Xinhua|English.news.cn\nhttp://www.xinhuanet.com/english/2020-01/09/c_138690570.htm"
},
{
"key": "ref3",
"unstructured": "Coronavirus Disease (COVID-19), Report 191\nhttps://www.who.int/docs/default-source/coronaviruse/situation-reports/20200729-covid-19-sitrep-191.pdf?sfvrsn=2c327e9e_2"
},
{
"article-title": "Does Angiotensin II receptor blockers increase the risk of SARS-CoV-2 infection? A real-life experience",
"author": "De Vito",
"first-page": "523",
"journal-title": "Eur. Rev. Med. Pharmacol. Sci.",
"key": "ref4",
"volume": "25",
"year": "2021"
},
{
"DOI": "10.1038/s41467-021-23498-x",
"doi-asserted-by": "publisher",
"key": "ref5"
},
{
"DOI": "10.1038/s41598-020-71188-3",
"doi-asserted-by": "publisher",
"key": "ref6"
},
{
"DOI": "10.1002/hed.26269",
"doi-asserted-by": "publisher",
"key": "ref7"
},
{
"article-title": "Clinical features, laboratory findings and predictors of death in hospitalized patients with COVID-19 in Sardinia, Italy",
"author": "De Vito",
"first-page": "7861",
"journal-title": "Eur. Rev. Med. Pharmacol. Sci.",
"key": "ref8",
"volume": "24",
"year": "2020"
},
{
"DOI": "10.1016/j.archger.2020.104058",
"doi-asserted-by": "publisher",
"key": "ref9"
},
{
"DOI": "10.1016/S0140-6736(20)30566-3",
"doi-asserted-by": "publisher",
"key": "ref10"
},
{
"DOI": "10.1111/ggi.13960",
"doi-asserted-by": "publisher",
"key": "ref11"
},
{
"DOI": "10.1159/000518490",
"doi-asserted-by": "publisher",
"key": "ref12"
},
{
"DOI": "10.3389/fmed.2021.779118",
"doi-asserted-by": "publisher",
"key": "ref13"
},
{
"DOI": "10.1016/j.jinf.2020.03.005",
"doi-asserted-by": "publisher",
"key": "ref14"
},
{
"DOI": "10.1183/13993003.00524-2020",
"doi-asserted-by": "publisher",
"key": "ref15"
},
{
"DOI": "10.1371/journal.pone.0248009",
"doi-asserted-by": "publisher",
"key": "ref16"
},
{
"DOI": "10.1016/j.thromres.2020.07.047",
"doi-asserted-by": "publisher",
"key": "ref17"
},
{
"DOI": "10.3855/jidc.13288",
"doi-asserted-by": "publisher",
"key": "ref18"
},
{
"DOI": "10.7573/dic.2020-10-3",
"doi-asserted-by": "publisher",
"key": "ref19"
},
{
"DOI": "10.1093/cid/ciac180",
"doi-asserted-by": "publisher",
"key": "ref20"
},
{
"DOI": "10.3892/mmr.2017.7546",
"doi-asserted-by": "publisher",
"key": "ref21"
},
{
"DOI": "10.1038/nature03712",
"doi-asserted-by": "publisher",
"key": "ref22"
},
{
"key": "ref23"
},
{
"DOI": "10.1016/j.jsbmb.2020.105771",
"doi-asserted-by": "publisher",
"key": "ref24"
},
{
"DOI": "10.3389/fpubh.2021.736665",
"doi-asserted-by": "publisher",
"key": "ref25"
},
{
"DOI": "10.1371/journal.pone.0263069",
"doi-asserted-by": "publisher",
"key": "ref26"
},
{
"DOI": "10.1126/science.1123933",
"doi-asserted-by": "publisher",
"key": "ref27"
},
{
"DOI": "10.4049/jimmunol.173.5.2909",
"doi-asserted-by": "publisher",
"key": "ref28"
},
{
"DOI": "10.1186/s12985-018-1035-2",
"doi-asserted-by": "publisher",
"key": "ref29"
},
{
"DOI": "10.1371/journal.pone.0025333",
"doi-asserted-by": "publisher",
"key": "ref30"
},
{
"DOI": "10.1016/j.genrep.2021.101270",
"doi-asserted-by": "publisher",
"key": "ref31"
},
{
"DOI": "10.1136/postgradmedj-2020-139542",
"doi-asserted-by": "publisher",
"key": "ref32"
},
{
"DOI": "10.1136/bmj.i6583",
"doi-asserted-by": "publisher",
"key": "ref33"
},
{
"DOI": "10.1210/er.2018-00126",
"doi-asserted-by": "publisher",
"key": "ref34"
},
{
"DOI": "10.1016/j.jsbmb.2020.105719",
"doi-asserted-by": "publisher",
"key": "ref35"
},
{
"DOI": "10.3390/nu12113377",
"doi-asserted-by": "publisher",
"key": "ref36"
},
{
"DOI": "10.1016/j.jsbmb.2020.105751",
"doi-asserted-by": "publisher",
"key": "ref37"
},
{
"DOI": "10.1001/jama.2020.26848",
"doi-asserted-by": "publisher",
"key": "ref38"
},
{
"DOI": "10.1186/s13063-022-06016-2",
"doi-asserted-by": "publisher",
"key": "ref39"
}
],
"reference-count": 39,
"references-count": 39,
"relation": {},
"resource": {
"primary": {
"URL": "https://www.mdpi.com/2227-9032/10/5/956"
}
},
"score": 1,
"short-title": [],
"source": "Crossref",
"subject": [
"Health Information Management",
"Health Informatics",
"Health Policy",
"Leadership and Management"
],
"subtitle": [],
"title": "Effectiveness of Vitamin D Supplements among Patients Hospitalized for COVID-19: Results from a Monocentric Matched-Cohort Study",
"type": "journal-article",
"volume": "10"
}
